Lipella Pharmaceuticals (LIPO) to Post Quarterly Earnings on Wednesday

Lipella Pharmaceuticals (NASDAQ:LIPO) will likely be releasing its resultson Wednesday, September 2nd. Analysts expect Lipella Pharmaceuticals to post earnings of ($1.28) per share and revenue of $0.1460 million for the quarter.

Lipella Pharmaceuticals Stock Performance

Shares of LIPO stock opened at $0.03 on Tuesday. The company’s fifty day simple moving average is $0.04 and its 200-day simple moving average is $0.08. Lipella Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0.64. The company has a market cap of $151,106.70, a PE ratio of -0.01 and a beta of 1.56.

About Lipella Pharmaceuticals

Lipella Pharmaceuticals Inc, a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).